AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MELBOURNE, July 1 Asia Pulse - Australia's Biotech Genetic Technologies Ltd (ASX:GTG) has announced plans to expand an AIDS research project acquired by its 60-per cent owned subsidiary Immunaid Pty Ltd.
GTG said it was in talks with a major United States life sciences company that had expressed interest to support GTG and to participate in the research project.
Immunaid was formed in March 2001 to acquire a project on immunodeficiency linked to retroviral infection, which was under way at the University of Western Australia.
GTG ...